PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $116,156 | -70.4% | 71,701 | +12.1% | 0.00% | -100.0% |
| Q3 2023 | $392,813 | -43.4% | 63,976 | -42.3% | 0.00% | -66.7% |
| Q2 2023 | $694,309 | -41.7% | 110,912 | -55.6% | 0.00% | -40.0% |
| Q1 2023 | $1,190,535 | +3.3% | 249,588 | +88.3% | 0.01% | -16.7% |
| Q4 2022 | $1,152,976 | +319.3% | 132,526 | +472.7% | 0.01% | +200.0% |
| Q3 2022 | $275,000 | -34.5% | 23,139 | +27.4% | 0.00% | -33.3% |
| Q4 2021 | $420,000 | – | 18,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |